| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |